Fosun International's total revenue in 2022 amounted to RMB175.39 Billion, up 8.7% Year-on-year
PR99861
HONG KONG, March 30, 2023 /PRNewswire=KYODO JBN/ --
Fosun International Limited (HKEX stock code: 00656, "Fosun International"),
together with its subsidiaries ("Fosun" or the "Group"), today announced its
annual results for the year ended 31 December 2022 (the "Reporting Period").
In 2022, the increasingly sophisticated macro environment, the US dollar
interest rate hikes, and geopolitical tensions continued to disrupt the
economy. Fosun firmly implemented a focused strategy, continued to lay the
solid foundation for its development, and achieved steady development in its
core businesses. During the Reporting Period, the Group achieved a total
revenue of RMB175.39 billion, representing a year-on-year increase of 8.7%.
Focusing on the needs of global families in health, happiness, and wealth, the
four core subsidiaries, namely Yuyuan, Fosun Pharma, Fosun Insurance Portugal,
and Fosun Tourism Group (FTG) continued to enhance their products and services,
accounting for 72% of the Group's total revenue. Among them, FTG's revenue
increased significantly by 49% to RMB13.78 billion. Due to the recurrent
outbreak of COVID-19 pandemic in 2022 and the turmoil and downturn of the
international capital markets, resulting in high business costs and an increase
in floating losses in secondary capital market investment, the Group's overall
industry operations and industrial investment have been affected to varying
degrees. During the Reporting Period, the net profit attributable to owners of
the parent amounted to RMB0.54 billion.
During the Reporting Period, Fosun continued to optimize its capital and asset
structure by actively managing its debt to effectively cope with violent
fluctuations in the capital market and maintain resilient liquidity. As of the
end of the Reporting Period, cash and bank balances and time deposits were
abundant, amounting to RMB100.56 billion; the ratio of total debt to total
capital was 53.2%, and down 3.6 percentage points compared to mid-2022; the
average cost of debt was at a low level of 4.7%; the adjusted NAV was HK$21.6
per share.
It is worth mentioning that in January 2023, the Group entered into a
syndicated loan agreement for an amount of RMB12 billion with eight domestic
banks, which was the largest private corporate syndicated loan led by five
major state-owned banks in cooperation with policy banks and joint-stock banks
since the announcement of "encouraging and supporting the development of the
private economy and private enterprises" at the Central Economic Working
Conference held in December 2022.
In 2022, Fosun's global operations capability was further enhanced, with
overseas revenue amounting to RMB77.4 billion, representing a year-on-year
increase of 14% and accounting for 44% of the total revenue. As of the end of
the Reporting Period, Fosun had 43 overseas brand enterprises and more than
45,000 overseas employees. The Group's R&D investment reached RMB10.4 billion,
representing a year-on-year increase of 17%; as of the end of 2022, Fosun had
1,771 patents for inventions.
The synergy capability of Fosun's FC2M global ecosystem was further enhanced,
highlighting the multiplier effect of the ecosystem. During the Reporting
Period, the Group's ecosystem has created a total value of more than RMB6.9
billion, and has 133 products that generated more than RMB100 million sales for
each, and among them 22 were new products; 50.8 million new registered members
during the year, representing a year-on-year increase of 27%. Among them, the
two top C-end platforms continued to facilitate the rapid and high-quality
growth of members. During the Reporting Period, Fosun Health acquired 9.24
million registered users, bringing the cumulative number of registered members
to 22.58 million. As of the end of the Reporting Period, Fosun Alliance has
accumulated 6.4 million registered members.
Since the beginning of 2023, businesses in consumer and tourism sectors have
shown a strong upward trend. In 2023, the Yuyuan Garden Lantern Festival which
received wide recognition in Chinese mainland and overseas became the talk of
the town and attracted more than 4 million visits, effectively driving
consumption in the area. Fosun's tourism business has rebounded rapidly,
Atlantis Sanya, a subsidiary of FTG, its business has fully recovered and
surpassed the level before the pandemic, recorded a business volume of RMB399
million in the first two months of 2023, representing an increase of 10%
compared to the same period of 2022, the average occupancy rate by room reached
96%. The business volume of Club Med and Lijiang FOLIDAY Town increased by 55%
and 149% respectively compared to the same period in 2022.
Guo Guangchang, Chairman of Fosun International, said: "Fosun firmly promoted
the strategy of focusing on its core businesses, made clear the positioning of
"a global innovation-driven consumer group" and the mission of "serving one
billion families worldwide". In the future, we will continue to strengthen
innovation, deepen global operations, and refine more good products and
services. With our endeavors, we hope to create happier lives for families."
SOURCE Fosun
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。